In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...

The global macular degeneration treatment market is poised for significant growth, projected to expand from USD 9.1 billion ...

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel ...

Birmingham researchers identified a target to reduce the risk of graft-versus-host-disease post stem cell transplant ...

Researchers working in Austria have observed in mice that some anti-inflammatories thwart the trick tumors use to evade ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...

“He came out as a match and that felt like a relief," says Kal, who is from north-west London. "My two younger sisters went ...